CompletedNCT00141271
Ziprasidone for depression in bipolarity type I
About this title
A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression
Read the official source — NCT00141271Medication studyAges 18+United States
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Birmingham and 71 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateJuly 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 536
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT00141271
- Official title
Show the full official title
A Six-Week, Randomized, Double-Blind, Multicenter, Fixed-Flexible Dose, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral Ziprasidone in Outpatients With Bipolar I Depression
Get this study by email
Recruitment & locations
CompletedBirmingham · Dana Point · La Mesa
60 more locations
- Laguna Hills
- Oceanside
- Orange
- San Diego
- Santa Ana
- Torrance
- Fort Lauderdale
- Gainesville
- Hialeah
- Jacksonville
- North Miami
- Orlando
- Winter Park
- Atlanta
- Maywood
- Naperville
- Schaumburg
- Greenwood
- Lafayette
- Prarie Village
- New Orleans
- Shreveport
- Boston
- Worcester
- Minneapolis
- Flowood
- St Louis
- Omaha
- Las Vegas
- Clementon
- Toms River
- New York
- Staten Island
- Cincinnati
- Cleveland
- Mayfield
- Oklahoma City
- Philadelphia
- Pittsburgh
- Charleston
- Columbia
- Memphis
- Nashville
- Bellaire
- Dallas
- DeSoto
- Galveston
- Houston
- Irving
- Plano
- Richardson
- San Antonio
- Wichita Falls
- Arlington
- Falls Church
- Richmond
- Virginia Beach
- Kirkland
- Milwaukee
- West Allis
Questions about this study
Who is behind this study?
The study sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Did this study involve medication?
Yes. The study involved medication, including Geodon (Ziprasidone) and Placebo.
Who was this study for?
Listed age limits: from 18 years.
